TVGN insider transactions
Tevogen Bio Holdings Inc. (TVGN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TVGN
- Officer Flomenberg Neal sold $6,635 worth of shares (972 units at $6.83), decreasing direct ownership by 1% to 76,940 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Executive Officer Saadi Ryan H. gifted 50,000 shares, decreasing direct ownership by 0.04% to 124,284,453 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Financial Officer Desai Kirti gifted 300,000 shares, decreasing direct ownership by 3% to 10,149,186 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Executive Officer Saadi Ryan H. gifted 460,000 shares, decreasing direct ownership by 0.37% to 124,334,453 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Executive Officer Saadi Ryan H. gifted 20,000 shares, decreasing direct ownership by 0.02% to 124,794,453 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Executive Officer Saadi Ryan H. was granted 8,000,000 shares, increasing direct ownership by 7% to 124,814,453 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Commercial Officer Khan Sadiq was granted 200,000 shares, increasing direct ownership by 21% to 1,169,618 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Financial Officer Desai Kirti was granted 750,000 shares, increasing direct ownership by 8% to 10,449,186 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Officer Flomenberg Neal was granted 300,000 shares, increasing direct ownership by 8% to 3,895,608 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Executive Officer Saadi Ryan H. sold $1,768,993 worth of shares (1,438,206 units at $1.23), decreasing direct ownership by 1% to 116,814,453 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Officer Flomenberg Neal sold $253,935 worth of shares (232,968 units at $1.09), decreasing direct ownership by 6% to 3,595,608 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Officer Flomenberg Neal sold $231,734 worth of shares (211,909 units at $1.09), decreasing direct ownership by 5% to 3,828,576 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Officer Flomenberg Neal sold $250,006 worth of shares (213,817 units at $1.17), decreasing direct ownership by 5% to 4,040,485 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Director Feike Jeffrey L. was granted 240,000 shares, increasing direct ownership by 41% to 821,771 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Director Patton Curtis L. was granted 240,000 shares, increasing direct ownership by 25% to 1,209,618 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Director Podlogar Susan M was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Director Sordillo Victor J. was granted 480,000 shares, increasing direct ownership by 495% to 576,962 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Director Goh Keow Lin was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Officer Flomenberg Neal sold $1,747,332 worth of shares (1,078,600 units at $1.62), decreasing direct ownership by 20% to 4,254,302 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Chief Financial Officer Desai Kirti bought $2,460 worth of shares (3,000 units at $0.82), increasing direct ownership by 0.03% to 9,699,186 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
- Saadi Ryan H. bought $2,000 worth of shares (2,607 units at $0.77), increasing direct ownership by 0.00% to 118,252,659 units (SEC Form 4)4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)